Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, anti-infective drugs, and other applications. Lionco Pharmaceutical Group Co.,Ltd. was founded in 2003 and is based in Shannan, China.
Frequently asked questions
What sector does Lionco Pharm Grp Co Ltd (603669) operate in?
Lionco Pharm Grp Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Lionco Pharm Grp Co Ltd (603669) current stock price?
As of the latest data, Lionco Pharm Grp Co Ltd stock price is CN¥5.48, with a previous close of CN¥5.27. Lionco Pharm Grp Co Ltd gained CN¥0.21 in the last trading session, representing a 3.98% increase.
What is Lionco Pharm Grp Co Ltd (603669) current market capitalization?
Lionco Pharm Grp Co Ltd market cap is approximately 3.90 billion.
What is Lionco Pharm Grp Co Ltd (603669) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.19.
Does Lionco Pharm Grp Co Ltd (603669) pay dividends?
No. Lionco Pharm Grp Co Ltd does not pay a dividend.
What is Lionco Pharm Grp Co Ltd (603669) beta (volatility) score?
Lionco Pharm Grp Co Ltd has a beta of 0.242, indicating lower volatility than the overall market.